SelectQuote emphasizes cash flow generation while experiencing a decline in revenue. Declining top line revenue may hinder SelectQuote's growth prospects and investor confidence.
| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | 1 | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | 1 | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2025 | ‡‡‡ |
|
| 2024 | ‡‡‡ |
|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Cash | 83.16 | 42.69 | 35.73 | 20.72 |
| Receivables | 995.06 | 1,031.35 | 1,102.22 | 1,158.23 |
| Inventory | — | — | — | — |
| Other | 13.00 | — | — | — |
| 1,078.22 | 1,074.04 | 1,137.95 | 1,178.95 |
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Payables | 27.58 | 36.59 | 59.21 | 74.03 |
| ST’ Debt | 33.88 | 45.85 | 68.52 | 22.01 |
| Other | 70.00 | — | — | — |
| 128.42 | 156.94 | 200.37 | 179.36 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | — | ‡‡‡ | ‡‡‡ |
| Earnings | — | ‡‡‡ | ‡‡‡ |
| Book Value | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 328.81 | 537.10 | 430.93 | 321.65 |
1,618.50
|
| ’25 | 292.26 | 481.07 | 408.16 | 345.10 |
1,526.59
|
| ’24 | 232.73 | 405.44 | 376.40 | 307.21 |
1,321.78
|
| ’23 | 162.48 | 319.19 | 299.40 | 221.78 |
1,002.85
|
| ’22 | 156.08 | 194.24 | 274.34 | 139.39 |
764.05
|
| ’21 | 124.17 | 357.57 | 265.35 | 182.90 |
929.98
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | (21.62) | 0.05 | 56.78 | (3.32) |
31.89
|
| ’25 | (16.61) | (28.69) | 71.12 | (37.48) |
(11.67)
|
| ’24 | (23.67) | (25.57) | 44.48 | 20.00 |
15.24
|
| ’23 | (47.17) | (28.40) | 62.74 | (6.54) |
(19.38)
|
| ’22 | (87.07) | (218.67) | 21.38 | (53.95) |
(338.31)
|
| ’21 | (9.35) | (93.80) | 42.20 | (54.49) |
(115.44)
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | (25.61) | (3.59) | 52.82 | (7.88) |
15.74
|
| ’25 | (19.18) | (30.97) | 67.76 | (40.59) |
(22.98)
|
| ’24 | (25.82) | (29.11) | 41.25 | 17.51 |
3.82
|
| ’23 | (49.55) | (30.49) | 60.35 | (8.81) |
(28.50)
|
| ’22 | (97.91) | (230.96) | 12.43 | (56.52) |
(372.96)
|
| ’21 | (13.68) | (98.68) | 39.09 | (65.16) |
(138.43)
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | (0.26) | 0.26 | 0.11 | (0.19) |
(0.06)
|
| ’25 | (0.26) | 0.30 | 0.03 | (0.02) |
0.01
|
| ’24 | (0.19) | 0.11 | 0.05 | (0.18) |
(0.20)
|
| ’23 | (0.26) | 0.14 | 0.06 | (0.29) |
(0.35)
|
| ’22 | (0.28) | (0.84) | (0.04) | (0.64) |
(1.81)
|
| ’21 | 0.01 | 0.55 | 0.22 | 0.02 |
0.79
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡ | 0.51 | 0.62 | 1.03 | 1.33 | 0.46 | — | — | — |
Low Price
|
| — | — | — | ‡‡‡‡ | ‡‡‡‡ | 9.42 | 2.94 | 4.46 | 6.86 | 1.76 | — | — | — |
High Price
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,367 | 4,186 | 4,292 | 4,269 | 4,039 | — | — | — |
Employees
|
| — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.17 | 0.24 | 0.31 | 0.36 | 0.40 | — | — | — |
Revenue/Emp
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 764.05 | 1,002.85 | 1,321.78 | 1,526.59 | 1,618.50 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 40.36% | 47.40% | 45.24% | 38.72% | 35.56% | — | — | — |
Gross Margin
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (389.81) | (69.14) | (29.07) | 48.51 | 76.29 | — | — | — |
EBT
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (51.02%) | (6.89%) | (2.20%) | 3.18% | 4.71% | ‡‡‡ | ‡‡‡ | — |
EBT Margin
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (297.50) | (58.54) | (34.12) | 47.58 | 62.19 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Net Income
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 74.78 | 36.56 | 31.14 | 25.71 | 21.78 | — | — | — |
Depreciation
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.66 | 6.04 | 7.84 | 8.67 | 8.60 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue/Sh
|
| — | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | (1.81) | (0.35) | (0.20) | 0.14 | (0.06) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Earnings/Sh
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.06) | (0.12) | 0.09 | (0.07) | 0.17 | — | — | — |
Cash Flow/Sh
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.21) | (0.05) | (0.07) | (0.06) | (0.09) | ‡‡‡ | ‡‡‡ | — |
Capex/Sh
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.27) | (0.17) | 0.02 | (0.13) | 0.08 | — | — | — |
Free CF/Sh
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.38 | 2.09 | 1.88 | 3.27 | 3.45 | — | — | — |
Book Value/Sh
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 164.04 | 166.14 | 168.52 | 176.15 | 188.17 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Shares
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 0.00 | 0.00 | 17.00 | 0.00 | ‡‡‡‡‡ | — | — |
PE Ratio
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.53 | 0.32 | 0.39 | 0.27 | 0.10 | ‡‡‡ | ‡‡‡ | — |
PS Ratio
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.04 | 0.93 | 1.63 | 1.19 | 0.45 | ‡‡‡ | ‡‡‡ | — |
PB Ratio
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.27 | 0.94 | 0.87 | 0.50 | 0.31 | ‡‡‡‡ | ‡‡‡‡ | — |
EV/Sales
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.60) | (32.96) | 302.46 | (33.45) | 32.25 | — | — | — |
EV/FCF
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (338.31) | (19.38) | 15.24 | (11.67) | 31.89 | ‡‡‡ | ‡‡‡ | — |
Op' Cash Flow
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (34.65) | (9.12) | (11.41) | (11.31) | (16.15) | — | — | — |
Capex
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (372.96) | (28.50) | 3.82 | (22.98) | 15.74 | — | — | — |
FCF
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,009.28 | 949.80 | 917.10 | 937.58 | 999.59 | — | — | — |
Working Cap'
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 705.59 | 698.51 | 683.33 | 385.11 | 370.17 | — | — | — |
Total Debt
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 564.60 | 615.35 | 640.64 | 349.38 | 349.45 | — | — | — |
Net Debt
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 391.11 | 346.97 | 316.80 | 575.52 | 650.03 | — | — | — |
Sh' Equity
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | (21.92%) | (4.67%) | (2.83%) | 2.05% | (0.92%) | — | — | — |
ROA
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (22.63%) | 0.75% | 4.21% | 4.63% | 4.62% | — | — | — |
ROIC
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (56.23%) | (15.86%) | (10.28%) | 7.50% | (3.31%) | — | — | — |
ROE
|
SelectQuote, Inc. (SLQT), once a pandemic-fueled insurtech darling that debuted via SPAC at a $6 billion peak in 2020 with shares soaring above $30, has endured a brutal post-boom reckoning—plummeting to sub-$2 lows amid margin squeezes and operational resets. Yet, the turnaround is underway: revenue has roared back with 31% growth to $1 billion in 2023 and 32% to $1.32 billion in 2024, driven by efficiency gains (revenue per employee at $308,000) and dominance in Medicare Advantage amid an aging U.S. population. Profitability is flickering positive, with 2024 net income at $48 million (ROE 7.5%) after deep losses, while aggressive deleveraging slashed debt 44% and positioned ROIC at 4.6%.
The stock’s disconnect from fundamentals screams opportunity: trading at a rock-bottom 0.27x PS ratio (versus peers’ 2-4x) and 0.11x 2026 sales estimates, despite revenue per share projected to double to $9.42 by then. A rare insider director buy in March 2025 signals board confidence, aligning with analyst targets implying 40-460% upside on earnings recovery, multiple expansion, and seasonal Medicare enrollment boosts. Risks like regulation persist, but demographic tailwinds and AI efficiencies fortify the moat.
This phoenix mid-rise—from survival to reacceleration—beckons patient investors eyeing substantial rerating as SLQT compounds toward $1.7 billion revenue by 2026.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.